RMR Wealth Builders’s AstraZeneca AZN Stock Holding History

RMR Wealth Builders’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$46K	Buy	+465	New	+$43.8K	0.04%	235

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RMR Wealth Builders's AZN Position: Q4 2019 in Review

RMR Wealth Builders opened a new position in AstraZeneca (AZN) in Q4 2019: 465 shares worth $46K. The stake represents 0.04% of the portfolio and ranks #235 among its holdings.

633 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

RMR Wealth Builders held 465 shares of AstraZeneca worth $46K as of Q4 2019.
AstraZeneca was a new RMR Wealth Builders position in Q4 2019.
AstraZeneca made up 0.04% of RMR Wealth Builders's portfolio in Q4 2019, its #235 holding.
633 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on RMR Wealth Builders's 13F filing for Q4 2019, filed 3 Mar 2020.